
Releases
Anixa Biosciences Secures South Korean Patent for Breast Cancer Vaccine
South Korea has granted Anixa Biosciences a composition-of-matter patent for its experimental breast cancer vaccine, extending the company’s intellectual property protection in the region through 2040. The move bolsters Anixa’s global footprint in a market currently grappling with a rising incidence of the disease among younger patients.

























